Cyclospora, Parsley outbreak: timeline
FDA posted this investigation on July 22, 2026. Its case count in FDA's table went from 72 on July 25, 2026 to 175 on Nov. 5, 2026. FDA closed it between Nov. 4, 2026 and Nov. 5, 2026.
Case count and what changed
The line is the case count each copy of FDA's table showed (a dot where it changed); A numbered mark is a step in the list below. Hover or tap for the dates.
Timeline
- July 22, 2026FDA posted investigation 1392 (Cyclospora, Parsley)
- between July 29, 2026 and Aug. 4, 2026Case count in FDA's table: 72 → 93
- between Aug. 4, 2026 and Aug. 5, 2026Case count in FDA's table: 93 → 115
- between Aug. 9, 2026 and Aug. 16, 2026Case count in FDA's table: 115 → 172
- between Aug. 16, 2026 and Aug. 20, 2026Case count in FDA's table: 172 → 201
- between Aug. 16, 2026 and Aug. 20, 2026FDA started sampling
- between Aug. 25, 2026 and Aug. 27, 2026Case count in FDA's table: 201 → 203
- between Aug. 27, 2026 and Sept. 2, 2026Case count in FDA's table: 203 → 225
- between Sept. 8, 2026 and Sept. 14, 2026Case count in FDA's table: 225 → 231
- between Sept. 15, 2026 and Sept. 18, 2026Case count in FDA's table: 231 → 234
- between Sept. 20, 2026 and Sept. 28, 2026Outbreak status: Ended See Advice
- between Sept. 28, 2026 and Oct. 1, 2026Case count in FDA's table: 234 → 235
- between Oct. 16, 2026 and Oct. 18, 2026Case count in FDA's table: 235 → 240
- between Oct. 21, 2026 and Oct. 22, 2026Case count in FDA's table: 240 → 241
- between Nov. 4, 2026 and Nov. 5, 2026FDA named the product: Parsley
- between Nov. 4, 2026 and Nov. 5, 2026Case count in FDA's table: 241 → 175
- between Nov. 4, 2026 and Nov. 5, 2026Investigation status: Closed (FDA closed the investigation)
FDA's table, copy by copy
| Copy of FDA's table | Cases | Product | Investigation | Outbreak |
|---|---|---|---|---|
| Nov. 12, 2026 | 175 | Parsley | Closed | Ended See Advice |
| Nov. 5, 2026 | 175 | Parsley | Closed | Ended See Advice |
| Oct. 22, 2026 | 241 | Not Yet Identified | Active | Ended See Advice |
| Oct. 18, 2026 | 240 | Not Yet Identified | Active | Ended See Advice |
| Oct. 1, 2026 | 235 | Not Yet Identified | Active | Ended See Advice |
| Sept. 28, 2026 | 234 | Not Yet Identified | Active | Ended See Advice |
| Sept. 18, 2026 | 234 | Not Yet Identified | Active | Ongoing See Advice |
| Sept. 14, 2026 | 231 | Not Yet Identified | Active | Ongoing See Advice |
| Sept. 2, 2026 | 225 | Not Yet Identified | Active | Ongoing See Advice |
| Aug. 27, 2026 | 203 | Not Yet Identified | Active | Ongoing See Advice |
| Aug. 20, 2026 | 201 | Not Yet Identified | Active | Ongoing See Advice |
| Aug. 16, 2026 | 172 | Not Yet Identified | Active | Ongoing See Advice |
| Aug. 5, 2026 | 115 | Not Yet Identified | Active | Ongoing See Advice |
| Aug. 4, 2026 | 93 | Not Yet Identified | Active | Ongoing See Advice |
| July 25, 2026 | 72 | Not Yet Identified | Active | Ongoing See Advice |
How this is put together
From FDA's table of outbreak investigations (CORE): the cells as FDA wrote them in each copy of the table we hold (310 copies since Nov. 18, 2020: the Internet Archive's, and from Oct. 22, 2026 our daily copy). A change is dated between the copy before it and the first copy that shows it; FDA may have made it on any day between. The company announcements are the ones FDA's own advisory for this investigation links to; nothing is matched by us. Only the copies where a cell changed are in the table. All investigations: outbreak investigations.